|1.||Ko, Wen-Chien: 7 articles (11/2013 - 11/2002)|
|2.||Cohen, R: 5 articles (11/2013 - 10/2000)|
|3.||Chuang, Yin-Ching: 5 articles (08/2012 - 11/2002)|
|4.||Hsueh, Po-Ren: 4 articles (08/2015 - 10/2005)|
|5.||Wu, Chi-Jung: 4 articles (11/2013 - 10/2005)|
|6.||Lee, Hsin-Chun: 4 articles (12/2011 - 10/2005)|
|7.||Lee, Nan-Yao: 4 articles (12/2011 - 10/2005)|
|8.||Chang, Chia-Ming: 4 articles (12/2011 - 10/2005)|
|9.||Saxena, Anil K: 3 articles (07/2012 - 11/2005)|
|10.||Panhotra, Bodh R: 3 articles (07/2012 - 11/2005)|
10/01/1990 - "Cefotaxime is effective as an empirical treatment of suspected infection due to susceptible organisms in immunocompromised patients and is of proven efficacy in serious, life-threatening infections in general. "
09/03/1982 - "The tissue concentrations were thus high enough to be effective against infections caused by cefotaxim-sensitive organisms. "
01/01/1977 - "Tests on different infection models also provided evidence of the high efficacy of HR 756 in vivo."
05/01/1992 - "We have compared the efficacy of a low dose of cefotaxime (2 g every 12 h) with a more usual dose (2 g every 8 h) in a prospective, randomized study of the treatment of chest infections in the seriously ill. "
05/01/1995 - "In the group with severe infection or severe underlying disease receiving 2 g 12-h cefotaxime, the overall clinical success rate (cured plus improved) was 98.4%. "
02/26/1981 - "Because cefotaxime is active at low concentration and has a good diffusion in the CSF, it provides a particularly effective treatment in Gram-negative meningitis in children. "
01/01/1988 - "Cefotaxime was safe and effective in treating Gram-negative enteric bacillary meningitis in infants and children and should be considered as a potential drug of choice in Gram-negative neonatal meningitis due to susceptible organisms."
09/01/1985 - "Cefotaxime in a dosage of 150 mg/kg/day divided every 6 hours intravenously seems safe and effective therapy for neonatal Gram-negative bacillary meningitis."
03/01/1982 - "Cefotaxime appears to be potentially useful in the management of gram-negative bacillary meningitis."
09/01/1985 - "First clinical signs were noted after 5 days of antibiotherapy (Cefotaxime); at that time the meningitis was cured and the bacteriologic studies yielded negative results. "
04/01/1986 - "Satisfactory efficacy of cefotaxime in treatment of premature infants with pneumonia during the first month of their life was shown. "
01/01/1992 - "Interim data, however, support the continued use of low-dose cefotaxime as an appropriate alternative for clinically effective and cost-effective management of nosocomially acquired pneumonia."
04/01/1995 - "Streptococcus pneumoniae was eradicated by cefotaxime, and pneumonia resolved. "
01/01/2009 - "The aim of the study was to evaluate therapeutic efficiency of ceftriabol (Russia) and claforan (both 3d generation cefalosporins) used to manage severe extrahospital pneumonia. "
05/01/1995 - "Results from this study support the use of cefotaxime as an alternative to empiric monotherapy for nosocomial pneumonia in surgical-service patients who are not neutropenic or on long-term artificial ventilation."
09/01/1984 - "The study demonstrates that cefotaxime is effective in the treatment of acute bacterial meningitis."
09/01/1989 - "Based on this clinical study, cefotaxime is an effective and safe drug for the treatment of childhood bacterial meningitis."
05/01/1995 - "Cefotaxime is an effective and safe drug for the treatment of childhood bacterial meningitis."
07/01/1985 - "Cefotaxime was found to be as safe and effective as standard therapy for the treatment of bacterial meningitis in children."
07/01/1986 - "We conclude that cefotaxime has similar efficacy when compared with conventional therapy for the management of bacterial meningitis in pediatric patients."
|5.||Respiratory Tract Infections (Respiratory Tract Infection)
01/01/1988 - "Therapeutic efficacy and tolerability of cefotaxime--a study of acute respiratory infections in chronic lung conditions."
09/01/1984 - "The results of this study indicate that cefotaxime is safe and effective in the therapy of acute bacterial lower respiratory tract infections."
09/01/1982 - "The efficacy of cefotaxime sodium for treatment of patients with lower respiratory infections was evaluated by three protocols in multicenter trials. "
12/01/1998 - "Results from this study support the use of twice-daily cefotaxime administration for the treatment of lower respiratory tract infections in pediatric patients."
06/01/1982 - "This study indicates that cefotaxime realizes significant bronchial amounts superior to MICs of microorganisms responsible for respiratory infections."
|8.||Cephalosporins (Cephalosporin Antibiotics)
|1.||Intensive Care (Surgical Intensive Care)
|3.||Drug Therapy (Chemotherapy)
|4.||Cesarean Section (Caesarean Section)